3 results
PrimaryObjectives: 1. Evaluate the efficacy of adding anacetrapib 100 mg for 52 weeks relative to placebo on plasma concentrations of LDL-C. 2. Evaluate the safety and tolerability of 52 weeks of treatment with anacetrapib 100 mg.Hypotheses: 1.…
The objective of this study is to assess the safety and effectiveness of the VENOVO * Venous Stent for the treatment of iliofemoral occlusive disease including Acute or Chronic Deep Vein Thombosis (DVT), May-Thurner Syndrome, or any combination of…
To determine RD of BLU-263To assess if treatment with BLU-263 improves outcomes compared to placebo + BSC, as assessed using the ISM-SAFTo assess the long-term safety and tolerability of treatment with BLU-263To assess the long-term efficacy of…